Need professional-grade analysis? Visit stockanalysis.com
$20.60B
23.09
6,787
3.24%
Apeloa Pharmaceutical Co Ltd (000739) trades on SHE in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY17.78, down 1.55% from the previous close.
Over the past year, 000739 has traded between a low of CNY12.95 and a high of CNY19.36. The stock has gained 36.1% over this period. It is currently 8.2% below its 52-week high.
Apeloa Pharmaceutical Co Ltd has a market capitalization of $20.60B, with a price-to-earnings ratio of 23.09 and a dividend yield of 3.24%.
Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects; pharmaceutical business includes anti-infective, cardiovascular, psychotropic, hepatobiliary and anti-tumor categories. The company also provides technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification; and controlled-release formulation development, taste masking technology, and particle flow simulation. In addition, it exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.